Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Due to the manufacture policy, the Cefprozil industry is relative concentrated, the manufacture technology is relative mature.

Market Analysis and Insights: Global Cefprozil Market
The global Cefprozil market is valued at US$ 134.7 million in 2019. The market size will reach US$ 144.5 million by the end of 2026, growing at a CAGR of 1.0% during 2021-2026.

Global Cefprozil Scope and Market Size
Cefprozil market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cefprozil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Anhydrous
Monohydrate

Segment by Application
Pharyngitis/tonsillitis
Otitis Media
Acute Sinusitis
Secondary Bacterial Infection
Uncomplicated Skin
Other

By Company
Orchid
Taj Pharma
Dhanuka
Lupin
Alkem
Corden Pharma
Aurobindo
Covalent
TEVA GROUP
Hetero Drugs
Qilu Antibiotics
Dongying Pharma
Union Chempharma
Huafangpharm
Topfond

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia